LONG-TERM EVOLUTION OF UNTREATED IDIOPATHIC MEMBRANOUS GLOMERULONEPHRITIS

被引:0
|
作者
MAZUECOS, AM [1 ]
PRAGA, M [1 ]
ARAQUE, A [1 ]
HERNANDEZ, E [1 ]
SANCHEZ, R [1 ]
ANDRES, A [1 ]
MORALES, JM [1 ]
RODICIO, JL [1 ]
机构
[1] HOSP 12 OCTUBRE,SERV NEFROL,CTRA ANDALUCIA KM 5400,E-28041 MADRID,SPAIN
来源
NEFROLOGIA | 1993年 / 13卷 / 04期
关键词
IDIOPATHIC MEMBRANOUS GLOMERULONEPHRITIS; PROGNOSIS; TREATMENT;
D O I
暂无
中图分类号
R5 [内科学]; R69 [泌尿科学(泌尿生殖系疾病)];
学科分类号
1002 ; 100201 ;
摘要
The indication for immunosuppressive treatment in idiopathic membranous glomerulonephritis is a very controversial issue, due to the variable evolution of this nephropathy Study of the spontaneous evolution of untreated cases should permit us to define high-risk groups in which these treatment could be beneficial. We analyze the evolution of 46 patients (30 males, 16 females) who did not receive immunosuppresive treatment. Follow-up was 60 +/- 40 months. Presentation was with nephrotic syndrome with normal function in 39 patients, non-nephrotic proteinuria with normal renal function in 4 and nephrotic syndrome with renal insufficiency (RI) in 3. At the end of follow-up 26 patients maintained normal renal function (Group I). Twelve of them reached a complete remission and 11 a partial remission. Two patients with partial remission later relapsed. The time elapsed between diagnosis and onset of remission was 28 +/- 12 months. The remaining 20 patients developed progressive RI (Group II), nine cases being on dialysis at the end of follow-up. With the exception of two cases, the onset of RI was established within the first 30 months of evolution. There was a significant difference between the two groups regarding age, blood pressure and initial serum creatinine. A remarkable dual evolution in the long-term follow-up is observed, towards remission proteinuria (45.6 % of the patiens) or towards RI (43,5 %). Both evolutions were defined within the first 30 months in the majority of patients. Given the high incidence of spontaneous remissions we think that immunosuppressive treatments should be restricted to those patients that develop RI.
引用
收藏
页码:299 / 305
页数:7
相关论文
共 50 条
  • [41] Comprehensive assessment of the long-term safety of pirfenidone in patients with idiopathic pulmonary fibrosis
    Valeyre, Dominique
    Albera, Carlo
    Bradford, Williamson Z.
    Costabel, Ulrich
    King, Talmadge E., Jr.
    Leff, Jonathan A.
    Noble, Paul W.
    Sahn, Steven A.
    du Bois, Roland M.
    RESPIROLOGY, 2014, 19 (05) : 740 - 747
  • [42] Improvement of clinic and serological long-term evolution of chronic Chagas disease patients treated with benznidazole
    Viotti, Rodolfo
    Vigliano, Carlos
    Lococo, Bruno
    Bertocchi, Graciela
    Petti, Marcos
    Gabriela Alvarez, Maria
    Armenti, Alejandro
    SALUD I CIENCIA, 2009, 16 (08): : 855 - 859
  • [43] Clinicopathological and long-term prognostic features of membranous nephropathy with crescents: a Japanese single-center experience
    Saito, Masaya
    Komatsuda, Atsushi
    Sato, Ryuta
    Saito, Ayano
    Kaga, Hajime
    Abe, Fumito
    Sawamura, Masato
    Nara, Mizuho
    Togashi, Masaru
    Okuyama, Shin
    Wakui, Hideki
    Takahashi, Naoto
    CLINICAL AND EXPERIMENTAL NEPHROLOGY, 2018, 22 (02) : 365 - 376
  • [44] Clinicopathological and long-term prognostic features of membranous nephropathy with crescents: a Japanese single-center experience
    Masaya Saito
    Atsushi Komatsuda
    Ryuta Sato
    Ayano Saito
    Hajime Kaga
    Fumito Abe
    Masato Sawamura
    Mizuho Nara
    Masaru Togashi
    Shin Okuyama
    Hideki Wakui
    Naoto Takahashi
    Clinical and Experimental Nephrology, 2018, 22 : 365 - 376
  • [45] Long-term follow-up of patients with infantile idiopathic scoliosis: is the rib vertebra angle difference (RVAD) a reliable indicator of evolution?
    Adam P. Lloyd
    Morgan E. B. Jones
    Adrian Gardner
    Matthew P. Newton Ede
    Spine Deformity, 2021, 9 : 579 - 585
  • [46] Long-term follow-up of patients with infantile idiopathic scoliosis: is the rib vertebra angle difference (RVAD) a reliable indicator of evolution?
    Lloyd, Adam P.
    Jones, Morgan E. B.
    Gardner, Adrian
    Newton Ede, Matthew P.
    SPINE DEFORMITY, 2021, 9 (02) : 579 - 585
  • [47] Phospholipase A2 Receptor-Positive Idiopathic Membranous Glomerulonephritis with Onset at 95 Years: Case Report
    Kubota, Keiichi
    Hoshino, Junichi
    Ueno, Toshiharu
    Mise, Koki
    Hazue, Ryo
    Sekine, Akinari
    Yabuuchi, Junko
    Yamanouchi, Masayuki
    Suwabe, Tatsuya
    Kikuchi, Koichi
    Sumida, Keiichi
    Hayami, Noriko
    Sawa, Naoki
    Takaichi, Kenmei
    Fujii, Takeshi
    Ohashi, Kenichi
    Akiyama, Shinichi
    Maruyama, Shoichi
    Ubara, Yoshifumi
    CASE REPORTS IN NEPHROLOGY AND DIALYSIS, 2016, 6 (02): : 76 - 82
  • [48] Insights into mildly dilated cardiomyopathy: temporal evolution and long-term prognosis
    Gigli, Marta
    Stolfo, Davide
    Merlo, Marco
    Barbati, Giulia
    Ramani, Federica
    Brun, Francesca
    Pinamonti, Bruno
    Sinagra, Gianfranco
    EUROPEAN JOURNAL OF HEART FAILURE, 2017, 19 (04) : 531 - 539
  • [49] Long-term results of children diagnosed with idiopathic nephrotic syndrome; single center experience
    Hacihamdioglu, Duygu Ovunc
    Kalman, Suleyman
    Gok, Faysal
    TURK PEDIATRI ARSIVI-TURKISH ARCHIVES OF PEDIATRICS, 2015, 50 (01): : 37 - 44
  • [50] Long-term follow-up of idiopathic thrombotic thrombocytopenic purpura treated with rituximab
    Chemnitz, Jens Marcus
    Uener, Jens
    Hallek, Michael
    Scheid, Christof
    ANNALS OF HEMATOLOGY, 2010, 89 (10) : 1029 - 1033